In This Section

NextGen Stars

AACR Annual Meeting 2027 NextGen Stars Program

The application is closed. The application deadline was September 23, 2026. Applicants will be notified of their status on late October.

Information for selected presenters

  • Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus 5 minutes for discussion, but the assigned length of the talk may vary depending on the session. 
  • Applicants who are selected to give talks at the Annual Meeting will receive travel support and complimentary registration for the meeting. 

Note Regarding Regular Abstract Submission

The submission of an extended abstract through this NextGen Stars application process is completely separate from the submission of a regular abstract for the AACR Annual Meeting 2027. Applicants will be notified of their status by late October. Those who are not selected as a NextGen Star but still wish to submit an abstract to the Annual Meeting must submit a separate abstract through the normal abstract submission process by the regular abstract deadline of Tuesday, November 10, 2026. 

Information for selected presenters

  • Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus five minutes for discussion, but the assigned length of the talk may vary depending on the session. 
  • Applicants who are selected to give talks at the Annual Meeting will receive travel support and complimentary registration for the meeting. 

Congratulations to the 2026 NextGen Stars

Jian Carrot-Zhang, PhD

Jian Carrot-Zhang, PhD

Assistant Professor
Memorial Sloan Kettering Cancer Center, New York, New York
Understand germline determinants of cancer progression using multi-ancestral real-world data

Steven Corsello, MD

Steven Corsello, MD

Alvaro Curiel Garcia, PhD

Alvaro Curiel Garcia, PhD

Associate Research Scientist
Columbia University Irving Medical Center, New York, New York
BMAL2 is a KRAS-driven master regulator of hypoxic adaptation and EMT in pancreatic ductal adenocarcinoma

William Freed-Pastor, MD, PhD

William Freed-Pastor, MD, PhD

Assistant Professor
Dana-Farber Cancer Institute, Boston, Massachusetts
Cancer-restricted cryptic antigens: Novel targets for next-generation T cell-based therapies

Adam Grippin, MD, PhD

Adam Grippin, MD, PhD

Resident/Post-doctoral candidate
UT MD Anderson Cancer Center, Houston, Texas
Mechanisms by which mRNA vaccines augment responses to immune checkpoint blockade

Long Nguyen, MD, PhD

Long Nguyen, MD, PhD

Instructor, Pathway-to-Independence
University of Chicago, Chicago, Illinois
BACH1 drives hypoxia-induced stem-like transition states and immune evasion in breast cancer

Amulya Sreekumar, PhD

Amulya Sreekumar, PhD

Research Associate
University of Pennsylvania, Philadelphia, Pennsylvania
Residual breast cancer cells co-opt SOX5-driven endochondral ossification to maintain dormancy

Daniel Zabransky, MD, PhD

Daniel Zabransky, MD, PhD

Assistant Professor
Johns Hopkins University, Baltimore, Maryland
Overcoming aging-driven barriers to effective immunotherapy in pancreatic cancer